Three recently discovered compounds have been identified as potent inhibitors of α-glucosidase—an enzyme that plays a crucial role in breaking down carbohydrates during digestion. Since this enzyme directly affects the rate at which sugars enter the bloodstream, the discovery points to promising new ingredients for functional foods designed to help manage type 2 diabetes.

Functional Foods and the Search for New Compounds

Functional foods offer not only basic nutrition but also additional health benefits. Many of these products contain natural molecules with antioxidant, neuroprotective, or blood sugar-lowering properties. However, finding such beneficial substances is complicated by the chemical complexity of food products. Traditional search methods are often slow and inefficient, so modern researchers use advanced tools such as nuclear magnetic resonance (NMR) and liquid chromatography–mass spectrometry (LC-MS/MS). These methods are especially useful for studying roasted coffee, which contains a wide range of overlapping chemical components.

New Study: Discovery of Antidiabetic Compounds in Coffee

A team of scientists led by Minhua Xu from the Kunming Institute of Botany, Chinese Academy of Sciences, published their findings in the journal Beverage Plant Research. Their work revealed previously unknown antidiabetic activity in coffee and expanded our understanding of its role as a functional food.

The researchers developed a three-step, activity-guided process to isolate bioactive diterpene esters from roasted Coffea arabica beans. This approach enabled them to detect both common and extremely rare compounds capable of inhibiting α-glucosidase, while also reducing solvent use and speeding up analysis.

Methodology and Key Findings

First, the raw diterpene extract was separated into 19 fractions using silica gel chromatography. Each fraction was analyzed by ¹H NMR and tested for α-glucosidase inhibition. Cluster analysis of NMR heatmap data identified fractions Fr.9–Fr.13 as the most biologically active.

Further analysis of fraction Fr.9 using ¹³C-DEPT NMR revealed the presence of an aldehyde group, confirming earlier results. After purification by semi-preparative HPLC, the scientists isolated three previously unknown diterpene esters, named cafaldehydes A, B, and C. Their chemical structures were confirmed using 1D and 2D NMR, as well as high-resolution mass spectrometry (HRESIMS).

Although the three cafaldehydes differed in their fatty acid composition (palmitic, stearic, and arachidic acids), all showed significant α-glucosidase inhibition. Their IC₅₀ values were 45.07, 24.40, and 17.50 μM, respectively, indicating higher activity than the reference drug acarbose.

Expanding the Search and Future Prospects

To identify additional trace compounds that were difficult to detect using only NMR or HPLC, the team applied LC-MS/MS to pooled fraction groups. They then constructed a molecular network using GNPS and Cytoscape. This analysis revealed three more previously unknown diterpene esters (compounds 4–6), structurally related to cafaldehydes A–C but containing different fatty acids (margaric, octadecenoic, and nonadecanoic acids). Database searches confirmed that these substances had not been described before.

Significance of the Results and Future Research

Overall, the results demonstrate that the integrated dereplication strategy is highly effective for identifying structurally diverse and biologically significant compounds in complex products such as roasted coffee.

The data open new possibilities for developing functional foods or nutraceuticals based on coffee that support glucose control and may aid in diabetes management. Beyond coffee, this low-solvent, high-precision screening approach can be applied to other complex food sources for rapid discovery of beneficial compounds. Future studies are planned to test the biological effects of the newly discovered diterpenes and to assess their safety and efficacy in vivo.